Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001–2013

Highlights • We analyse the trend of invasive pneumococcal disease in the 13-valent vaccine era. • The incidence of cases has declined notably in children and moderately in adults. • The incidence of cases due to vaccine serotypes decreased 81% in children <5 years. • The moderate decline in adul...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 32; no. 22; pp. 2553 - 2562
Main Authors Guevara, Marcela, Ezpeleta, Carmen, Gil-Setas, Alberto, Torroba, Luis, Beristain, Xabier, Aguinaga, Aitziber, García-Irure, José Javier, Navascués, Ana, García-Cenoz, Manuel, Castilla, Jesús
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Ltd 07.05.2014
Elsevier
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Highlights • We analyse the trend of invasive pneumococcal disease in the 13-valent vaccine era. • The incidence of cases has declined notably in children and moderately in adults. • The incidence of cases due to vaccine serotypes decreased 81% in children <5 years. • The moderate decline in adults suggests the indirect effect of vaccination. • No changes indicating serotype replacement have been detected.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2014.03.054